Data as of Dec 26
| +0.70 / +3.17%|
Omeros Corp. is a clinical stage biopharmaceutical company, which engages in the discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. Its products are derived from its proprietary PharmacoSurgery platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. The company also has a deep and diverse pipeline of preclinical programs as well as a platform capable of unlocking new drug targets. Omeros was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
|Gregory A. Demopulos||Chairman, President & Chief Executive Officer|
|David R. Toll||Senior Director-Finance|
|Michael A. Jacobsen||Chief Financial Officer, Treasurer, CAO & VP|
|George A. Gaitanaris||Chief Scientific Officer & Vice President|
|J. Steven Whitaker||Chief Medical Officer & VP-Clinical Development|